Skip to main content
Clinical Trials/CTRI/2018/01/011570
CTRI/2018/01/011570
Recruiting
N/A

A multicenter, prospective, longitudinal registry of patients with prostate cancer in Asia - Not Applicable

Janssen Research Development LLC0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: null- Prostate cancer
Sponsor
Janssen Research Development LLC
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male aged 21 years or older \- Documented diagnosis of PC with either: High\-risk localized PC; Nonmetastatic, biochemically recurrent PC;
  • Metastatic PC \- Signed participation agreement/Informed Consent Form (ICF) by the patient or a legally acceptable
  • representative \- Agree to be followed\-up for PC per routine clinical care

Exclusion Criteria

  • No Specific Exclusion Criteria were defined

Outcomes

Primary Outcomes

Not specified

Similar Trials